Roche Holding Ltd. (NASDAQ:RHHBY) has earned an average recommendation of “Hold” from the thirteen research firms that are presently covering the stock, MarketBeat Ratings reports. Two investment analysts have rated the stock with a sell rating, seven have issued a hold rating and four have assigned a buy rating to the company. The average 1-year price target among brokerages that have updated their coverage on the stock in the last year is $38.00.

RHHBY has been the subject of several research analyst reports. Societe Generale cut Roche Holding from a “buy” rating to a “hold” rating in a report on Friday, June 30th. BNP Paribas cut Roche Holding from a “neutral” rating to an “underperform” rating in a report on Tuesday, September 26th. Cowen and Company set a $38.00 price objective on Roche Holding and gave the stock a “buy” rating in a report on Monday, July 10th. Deutsche Bank AG cut Roche Holding from a “buy” rating to a “hold” rating in a report on Friday, July 7th. Finally, Berenberg Bank cut Roche Holding from a “buy” rating to a “hold” rating in a report on Tuesday.

Shares of Roche Holding (RHHBY) traded down 0.90% during trading on Thursday, hitting $28.67. The stock had a trading volume of 3,523,423 shares. The company has a market capitalization of $195.70 billion and a PE ratio of 19.30. Roche Holding has a 52 week low of $25.25 and a 52 week high of $36.82. The firm has a 50-day moving average price of $31.41 and a 200 day moving average price of $32.12.

A number of large investors have recently bought and sold shares of RHHBY. Fisher Asset Management LLC increased its holdings in shares of Roche Holding by 34.7% in the third quarter. Fisher Asset Management LLC now owns 15,992,640 shares of the company’s stock worth $510,720,000 after purchasing an additional 4,117,258 shares during the last quarter. Parametric Portfolio Associates LLC increased its holdings in shares of Roche Holding by 12.3% in the second quarter. Parametric Portfolio Associates LLC now owns 3,652,015 shares of the company’s stock worth $116,134,000 after purchasing an additional 400,190 shares during the last quarter. Capital Counsel LLC NY increased its holdings in shares of Roche Holding by 30.5% in the second quarter. Capital Counsel LLC NY now owns 1,428,387 shares of the company’s stock worth $45,423,000 after purchasing an additional 334,008 shares during the last quarter. Bristol John W & Co. Inc. NY increased its holdings in shares of Roche Holding by 13.1% in the second quarter. Bristol John W & Co. Inc. NY now owns 2,327,621 shares of the company’s stock worth $74,193,000 after purchasing an additional 269,099 shares during the last quarter. Finally, Icon Advisers Inc. Co. bought a new stake in shares of Roche Holding in the second quarter worth about $4,617,000.

ILLEGAL ACTIVITY WARNING: “Roche Holding Ltd. (RHHBY) Given Consensus Rating of “Hold” by Brokerages” was originally posted by American Banking News and is the property of of American Banking News. If you are reading this report on another site, it was stolen and republished in violation of United States & international copyright legislation. The legal version of this report can be viewed at https://www.americanbankingnews.com/2017/10/26/roche-holding-ltd-rhhby-given-consensus-rating-of-hold-by-brokerages.html.

About Roche Holding

Roche Holding AG (Roche) is a research-based healthcare company. The Company’s operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics.

Analyst Recommendations for Roche Holding (NASDAQ:RHHBY)

Receive News & Ratings for Roche Holding Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche Holding Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.